Alan P Venook - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alan P Venook

Showing results (161-170 of 246) with videos related to

Pageof 25

Sort By:

Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2016

Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational studyMasatoshi Kudo, Riccardo Lencioni, Jorge A Marrero, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2015

A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic AdenocarcinomaAndrew H Ko, Tanios Bekaii-Saab, Jessica Van Ziffle, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2020

Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot TrialErin L Van Blarigan, Stacey A Kenfield, June M Chan, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2008

NCCN Task Force Report: mTOR inhibition in solid tumorsRobert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021

Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) TrialKaryn A Goodman, Fang-Shu Ou, Nathan C Hall, et al.

Nature Communications|September 18, 2022

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancerRadia M Johnson, Xueping Qu, Chu-Fang Lin, et al.

Global Advances in Health and Medicine|February 17, 2022

<i>Being Present 2.0</i>: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and CaregiversHannah M Dragomanovich, Anand Dhruva, Eve Ekman, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.

Annals of Surgical Oncology|October 28, 2022

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)M Margaret Kemeny, Fengmin Zhao, Arlene A Forastiere, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal CancerRyan B Corcoran, Chloe E Atreya, Gerald S Falchook, et al.

Pageof 25

Search research articles

Showing results (161-170 of 246) with videos related to

Sort By:

Pageof 25

Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2016

Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational studyMasatoshi Kudo, Riccardo Lencioni, Jorge A Marrero, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2015

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2020

Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot TrialErin L Van Blarigan, Stacey A Kenfield, June M Chan, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2008

NCCN Task Force Report: mTOR inhibition in solid tumorsRobert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021

Nature Communications|September 18, 2022

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancerRadia M Johnson, Xueping Qu, Chu-Fang Lin, et al.

Global Advances in Health and Medicine|February 17, 2022

<i>Being Present 2.0</i>: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and CaregiversHannah M Dragomanovich, Anand Dhruva, Eve Ekman, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021

Annals of Surgical Oncology|October 28, 2022

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal CancerRyan B Corcoran, Chloe E Atreya, Gerald S Falchook, et al.

Pageof 25